Biotin-PEG4-NHS ester
貨號 | 數量 | 價格 | 交貨時間 | 購買此產品 |
---|---|---|---|---|
2893-100mg | 100 mg | $145 | 現貨 | |
2893-1g | 1 g |
$590
|
現貨 |
Biotin-PEG4-NHS ester is an activated ester for simple and efficient biotin labeling of antibodies, proteins, and other primary amine-containing biomolecules. The NHS ester group reacts efficiently with amino groups by the nucleophilic attack, forming an amide bond and releasing N-Hydroxysuccinimide. Biotin-labeled compounds can then be linked to avidin or streptavidin for further purification or detection. The biotin group is relatively small and doesn’t affect the biological activity of biotinylated proteins.
This reagent features a long PEG4-linker that separates the biotin residue from the target molecule, ensuring efficient binding to avidin or streptavidin. The linker also increases the compound’s water solubility, thereby facilitating bioconjugation. Antibodies labeled with Biotin-PEG4-NHS ester exhibit less aggregation when stored in solution than those labeled with reagents with only hydrocarbon spacers.
顧客還購買了這個產品
FAM 醯肼,6-異構體 (FAM hydrazide, 6-isomer)
6-FAM 醯肼是一種羰基反應性螢光素 (FAM) 衍生物。該產品含有一個純的6-異構體的螢光素。dsSafe 核酸凝膠染色液,10,000 倍 (dsSafe Nucleic Acid Gel Staining Solution, 10,000×)
螢光染料,用於 DNA 和 RNA 凝膠顯色,是溴化乙錠的最佳安全替代品。AF 488 streptavidin
AF 488 conjugate of streptavidin, a high-affinity biotin-binding protein, for immunofluorescence, western blots, microplate assays, and other applications use.General properties
Appearance: | white to off-beige powder |
Molecular weight: | 588.68 |
CAS number: | 459426-22-3 |
Molecular formula: | C25H40N4O10S |
Solubility: | water, DMSO, DMF, DCM |
Quality control: | NMR 1H and HPLC-MS (95+%) |
Storage conditions: | 12 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Desiccate. |
MSDS: | 下載 |
產品規格 |
產品引用
- Zhang, L.; Yang, C.; Li, Y.; Niu, S.; Liang, X.; Zhang, Z.; Luo, Q.; Luo, H. Dynamic Changes in the Levels of Amyloid-β 42 Species in the Brain and Periphery of APP/PS1 Mice and Their Significance for Alzheimer’s Disease. Frontiers in Molecular Neuroscience, 2021, 14, 723317. doi: 10.3389/fnmol.2021.723317
